 | • レポートコード：MRC2-11QY05450 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はドライアイ疾患のグローバル市場について調査・分析したレポートです。種類別（人工涙液、抗炎症薬（シクロスポリン、コルチコステロイド、リフィテグラスト）、涙点プラグ、分泌促進薬）市場規模、用途別（病院薬局、独立薬局＆ドラッグストア、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ドライアイ疾患の競争状況、市場シェア ・世界のドライアイ疾患市場：種類別市場規模 2015年-2020年（人工涙液、抗炎症薬（シクロスポリン、コルチコステロイド、リフィテグラスト）、涙点プラグ、分泌促進薬） ・世界のドライアイ疾患市場：種類別市場規模予測 2021年-2026年（人工涙液、抗炎症薬（シクロスポリン、コルチコステロイド、リフィテグラスト）、涙点プラグ、分泌促進薬） ・世界のドライアイ疾患市場：用途別市場規模 2015年-2020年（病院薬局、独立薬局＆ドラッグストア、オンライン薬局） ・世界のドライアイ疾患市場：用途別市場規模予測 2021年-2026年（病院薬局、独立薬局＆ドラッグストア、オンライン薬局） ・北米のドライアイ疾患市場分析：米国、カナダ ・ヨーロッパのドライアイ疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのドライアイ疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のドライアイ疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのドライアイ疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Santen、Novartis、llergan、Takeda、TRB Chemedica、Sun Pharmaceutical、Senju、Sentiss Pharma、Johnson & Johnson、Otsuka、Mitotech、FCI ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
Market Analysis and Insights: Global Dry Eye Disease Market
The global Dry Eye Disease market size is projected to reach US$ 2471.6 million by 2026, from US$ 2405.2 million in 2020, at a CAGR of 2.6%% during 2021-2026.
Global Dry Eye Disease Scope and Market Size
Dry Eye Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dry Eye Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dry Eye Disease market is segmented into
Artificial Tears
Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
Punctal Plugs
Secretagogue
Segment by Application, the Dry Eye Disease market is segmented into
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online pharmacies
Regional and Country-level Analysis
The Dry Eye Disease market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dry Eye Disease market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dry Eye Disease Market Share Analysis
Dry Eye Disease market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dry Eye Disease business, the date to enter into the Dry Eye Disease market, Dry Eye Disease product introduction, recent developments, etc.
The major vendors covered:
Santen
Novartis
llergan
Takeda
TRB Chemedica
Sun Pharmaceutical
Senju
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
1 Study Coverage
1.1 Dry Eye Disease Product Introduction
1.2 Market Segments
1.3 Key Dry Eye Disease Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dry Eye Disease Market Size Growth Rate by Type
1.4.2 Artificial Tears
1.4.3 Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
1.4.4 Punctal Plugs
1.4.5 Secretagogue
1.5 Market by Application
1.5.1 Global Dry Eye Disease Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies & Drug Stores
1.5.4 Online pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dry Eye Disease Market Size, Estimates and Forecasts
2.1.1 Global Dry Eye Disease Revenue 2015-2026
2.1.2 Global Dry Eye Disease Sales 2015-2026
2.2 Global Dry Eye Disease, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dry Eye Disease Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dry Eye Disease Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dry Eye Disease Competitor Landscape by Players
3.1 Dry Eye Disease Sales by Manufacturers
3.1.1 Dry Eye Disease Sales by Manufacturers (2015-2020)
3.1.2 Dry Eye Disease Sales Market Share by Manufacturers (2015-2020)
3.2 Dry Eye Disease Revenue by Manufacturers
3.2.1 Dry Eye Disease Revenue by Manufacturers (2015-2020)
3.2.2 Dry Eye Disease Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dry Eye Disease Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dry Eye Disease Revenue in 2019
3.2.5 Global Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dry Eye Disease Price by Manufacturers
3.4 Dry Eye Disease Manufacturing Base Distribution, Product Types
3.4.1 Dry Eye Disease Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dry Eye Disease Product Type
3.4.3 Date of International Manufacturers Enter into Dry Eye Disease Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dry Eye Disease Market Size by Type (2015-2020)
4.1.1 Global Dry Eye Disease Sales by Type (2015-2020)
4.1.2 Global Dry Eye Disease Revenue by Type (2015-2020)
4.1.3 Dry Eye Disease Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dry Eye Disease Market Size Forecast by Type (2021-2026)
4.2.1 Global Dry Eye Disease Sales Forecast by Type (2021-2026)
4.2.2 Global Dry Eye Disease Revenue Forecast by Type (2021-2026)
4.2.3 Dry Eye Disease Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dry Eye Disease Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dry Eye Disease Market Size by Application (2015-2020)
5.1.1 Global Dry Eye Disease Sales by Application (2015-2020)
5.1.2 Global Dry Eye Disease Revenue by Application (2015-2020)
5.1.3 Dry Eye Disease Price by Application (2015-2020)
5.2 Dry Eye Disease Market Size Forecast by Application (2021-2026)
5.2.1 Global Dry Eye Disease Sales Forecast by Application (2021-2026)
5.2.2 Global Dry Eye Disease Revenue Forecast by Application (2021-2026)
5.2.3 Global Dry Eye Disease Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dry Eye Disease by Country
6.1.1 North America Dry Eye Disease Sales by Country
6.1.2 North America Dry Eye Disease Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dry Eye Disease Market Facts & Figures by Type
6.3 North America Dry Eye Disease Market Facts & Figures by Application
7 Europe
7.1 Europe Dry Eye Disease by Country
7.1.1 Europe Dry Eye Disease Sales by Country
7.1.2 Europe Dry Eye Disease Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dry Eye Disease Market Facts & Figures by Type
7.3 Europe Dry Eye Disease Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dry Eye Disease by Region
8.1.1 Asia Pacific Dry Eye Disease Sales by Region
8.1.2 Asia Pacific Dry Eye Disease Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dry Eye Disease Market Facts & Figures by Type
8.3 Asia Pacific Dry Eye Disease Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dry Eye Disease by Country
9.1.1 Latin America Dry Eye Disease Sales by Country
9.1.2 Latin America Dry Eye Disease Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dry Eye Disease Market Facts & Figures by Type
9.3 Central & South America Dry Eye Disease Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dry Eye Disease by Country
10.1.1 Middle East and Africa Dry Eye Disease Sales by Country
10.1.2 Middle East and Africa Dry Eye Disease Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dry Eye Disease Market Facts & Figures by Type
10.3 Middle East and Africa Dry Eye Disease Market Facts & Figures by Application
11 Company Profiles
11.1 Santen
11.1.1 Santen Corporation Information
11.1.2 Santen Description and Business Overview
11.1.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Dry Eye Disease Products Offered
11.1.5 Santen Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Dry Eye Disease Products Offered
11.2.5 Novartis Related Developments
11.3 llergan
11.3.1 llergan Corporation Information
11.3.2 llergan Description and Business Overview
11.3.3 llergan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 llergan Dry Eye Disease Products Offered
11.3.5 llergan Related Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Description and Business Overview
11.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Dry Eye Disease Products Offered
11.4.5 Takeda Related Developments
11.5 TRB Chemedica
11.5.1 TRB Chemedica Corporation Information
11.5.2 TRB Chemedica Description and Business Overview
11.5.3 TRB Chemedica Sales, Revenue and Gross Margin (2015-2020)
11.5.4 TRB Chemedica Dry Eye Disease Products Offered
11.5.5 TRB Chemedica Related Developments
11.6 Sun Pharmaceutical
11.6.1 Sun Pharmaceutical Corporation Information
11.6.2 Sun Pharmaceutical Description and Business Overview
11.6.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sun Pharmaceutical Dry Eye Disease Products Offered
11.6.5 Sun Pharmaceutical Related Developments
11.7 Senju
11.7.1 Senju Corporation Information
11.7.2 Senju Description and Business Overview
11.7.3 Senju Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Senju Dry Eye Disease Products Offered
11.7.5 Senju Related Developments
11.8 Sentiss Pharma
11.8.1 Sentiss Pharma Corporation Information
11.8.2 Sentiss Pharma Description and Business Overview
11.8.3 Sentiss Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sentiss Pharma Dry Eye Disease Products Offered
11.8.5 Sentiss Pharma Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Description and Business Overview
11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson Dry Eye Disease Products Offered
11.9.5 Johnson & Johnson Related Developments
11.10 Otsuka
11.10.1 Otsuka Corporation Information
11.10.2 Otsuka Description and Business Overview
11.10.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Otsuka Dry Eye Disease Products Offered
11.10.5 Otsuka Related Developments
11.1 Santen
11.1.1 Santen Corporation Information
11.1.2 Santen Description and Business Overview
11.1.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Santen Dry Eye Disease Products Offered
11.1.5 Santen Related Developments
11.12 FCI
11.12.1 FCI Corporation Information
11.12.2 FCI Description and Business Overview
11.12.3 FCI Sales, Revenue and Gross Margin (2015-2020)
11.12.4 FCI Products Offered
11.12.5 FCI Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dry Eye Disease Market Estimates and Projections by Region
12.1.1 Global Dry Eye Disease Sales Forecast by Regions 2021-2026
12.1.2 Global Dry Eye Disease Revenue Forecast by Regions 2021-2026
12.2 North America Dry Eye Disease Market Size Forecast (2021-2026)
12.2.1 North America: Dry Eye Disease Sales Forecast (2021-2026)
12.2.2 North America: Dry Eye Disease Revenue Forecast (2021-2026)
12.2.3 North America: Dry Eye Disease Market Size Forecast by Country (2021-2026)
12.3 Europe Dry Eye Disease Market Size Forecast (2021-2026)
12.3.1 Europe: Dry Eye Disease Sales Forecast (2021-2026)
12.3.2 Europe: Dry Eye Disease Revenue Forecast (2021-2026)
12.3.3 Europe: Dry Eye Disease Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dry Eye Disease Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dry Eye Disease Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dry Eye Disease Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dry Eye Disease Market Size Forecast by Region (2021-2026)
12.5 Latin America Dry Eye Disease Market Size Forecast (2021-2026)
12.5.1 Latin America: Dry Eye Disease Sales Forecast (2021-2026)
12.5.2 Latin America: Dry Eye Disease Revenue Forecast (2021-2026)
12.5.3 Latin America: Dry Eye Disease Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dry Eye Disease Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dry Eye Disease Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dry Eye Disease Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dry Eye Disease Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dry Eye Disease Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dry Eye Disease Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dry Eye Disease Market Segments
Table 2. Ranking of Global Top Dry Eye Disease Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dry Eye Disease Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Artificial Tears
Table 5. Major Manufacturers of Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
Table 6. Major Manufacturers of Punctal Plugs
Table 7. Major Manufacturers of Secretagogue
Table 8. Global Dry Eye Disease Market Size Growth Rate by Application 2020-2026 (Kg)
Table 9. Global Dry Eye Disease Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 10. Global Dry Eye Disease Sales by Regions 2015-2020 (Kg)
Table 11. Global Dry Eye Disease Sales Market Share by Regions (2015-2020)
Table 12. Global Dry Eye Disease Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Dry Eye Disease Sales by Manufacturers (2015-2020) (Kg)
Table 14. Global Dry Eye Disease Sales Share by Manufacturers (2015-2020)
Table 15. Global Dry Eye Disease Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Dry Eye Disease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Disease as of 2019)
Table 17. Dry Eye Disease Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Dry Eye Disease Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Dry Eye Disease Price (2015-2020) (USD/Kg)
Table 20. Dry Eye Disease Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Dry Eye Disease Product Type
Table 22. Date of International Manufacturers Enter into Dry Eye Disease Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 25. Global Dry Eye Disease Sales Share by Type (2015-2020)
Table 26. Global Dry Eye Disease Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Dry Eye Disease Revenue Share by Type (2015-2020)
Table 28. Dry Eye Disease Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 29. Global Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 30. Global Dry Eye Disease Sales Share by Application (2015-2020)
Table 31. North America Dry Eye Disease Sales by Country (2015-2020) (Kg)
Table 32. North America Dry Eye Disease Sales Market Share by Country (2015-2020)
Table 33. North America Dry Eye Disease Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Dry Eye Disease Revenue Market Share by Country (2015-2020)
Table 35. North America Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 36. North America Dry Eye Disease Sales Market Share by Type (2015-2020)
Table 37. North America Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 38. North America Dry Eye Disease Sales Market Share by Application (2015-2020)
Table 39. Europe Dry Eye Disease Sales by Country (2015-2020) (Kg)
Table 40. Europe Dry Eye Disease Sales Market Share by Country (2015-2020)
Table 41. Europe Dry Eye Disease Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Dry Eye Disease Revenue Market Share by Country (2015-2020)
Table 43. Europe Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 44. Europe Dry Eye Disease Sales Market Share by Type (2015-2020)
Table 45. Europe Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 46. Europe Dry Eye Disease Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Dry Eye Disease Sales by Region (2015-2020) (Kg)
Table 48. Asia Pacific Dry Eye Disease Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Dry Eye Disease Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Dry Eye Disease Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 52. Asia Pacific Dry Eye Disease Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 54. Asia Pacific Dry Eye Disease Sales Market Share by Application (2015-2020)
Table 55. Latin America Dry Eye Disease Sales by Country (2015-2020) (Kg)
Table 56. Latin America Dry Eye Disease Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Dry Eye Disease Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Dry Eye Disease Revenue Market Share by Country (2015-2020)
Table 59. Latin America Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 60. Latin America Dry Eye Disease Sales Market Share by Type (2015-2020)
Table 61. Latin America Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 62. Latin America Dry Eye Disease Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Dry Eye Disease Sales by Country (2015-2020) (Kg)
Table 64. Middle East and Africa Dry Eye Disease Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Dry Eye Disease Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Dry Eye Disease Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Dry Eye Disease Sales by Type (2015-2020) (Kg)
Table 68. Middle East and Africa Dry Eye Disease Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Dry Eye Disease Sales by Application (2015-2020) (Kg)
Table 70. Middle East and Africa Dry Eye Disease Sales Market Share by Application (2015-2020)
Table 71. Santen Corporation Information
Table 72. Santen Description and Major Businesses
Table 73. Santen Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 74. Santen Product
Table 75. Santen Recent Development
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. llergan Corporation Information
Table 82. llergan Description and Major Businesses
Table 83. llergan Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. llergan Product
Table 85. llergan Recent Development
Table 86. Takeda Corporation Information
Table 87. Takeda Description and Major Businesses
Table 88. Takeda Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Takeda Product
Table 90. Takeda Recent Development
Table 91. TRB Chemedica Corporation Information
Table 92. TRB Chemedica Description and Major Businesses
Table 93. TRB Chemedica Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. TRB Chemedica Product
Table 95. TRB Chemedica Recent Development
Table 96. Sun Pharmaceutical Corporation Information
Table 97. Sun Pharmaceutical Description and Major Businesses
Table 98. Sun Pharmaceutical Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. Sun Pharmaceutical Product
Table 100. Sun Pharmaceutical Recent Development
Table 101. Senju Corporation Information
Table 102. Senju Description and Major Businesses
Table 103. Senju Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Senju Product
Table 105. Senju Recent Development
Table 106. Sentiss Pharma Corporation Information
Table 107. Sentiss Pharma Description and Major Businesses
Table 108. Sentiss Pharma Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Sentiss Pharma Product
Table 110. Sentiss Pharma Recent Development
Table 111. Johnson & Johnson Corporation Information
Table 112. Johnson & Johnson Description and Major Businesses
Table 113. Johnson & Johnson Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. Johnson & Johnson Product
Table 115. Johnson & Johnson Recent Development
Table 116. Otsuka Corporation Information
Table 117. Otsuka Description and Major Businesses
Table 118. Otsuka Dry Eye Disease Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Otsuka Product
Table 120. Otsuka Recent Development
Table 121. Mitotech Corporation Information
Table 122. Mitotech Description and Major Businesses
Table 123. Mitotech Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Mitotech Product
Table 125. Mitotech Recent Development
Table 126. FCI Corporation Information
Table 127. FCI Description and Major Businesses
Table 128. FCI Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 129. FCI Product
Table 130. FCI Recent Development
Table 131. Global Dry Eye Disease Sales Forecast by Regions (2021-2026) (Kg)
Table 132. Global Dry Eye Disease Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Dry Eye Disease Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Dry Eye Disease Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Dry Eye Disease Sales Forecast by Country (2021-2026) (Kg)
Table 136. North America: Dry Eye Disease Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Dry Eye Disease Sales Forecast by Country (2021-2026) (Kg)
Table 138. Europe: Dry Eye Disease Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Dry Eye Disease Sales Forecast by Region (2021-2026) (Kg)
Table 140. Asia Pacific: Dry Eye Disease Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Dry Eye Disease Sales Forecast by Country (2021-2026) (Kg)
Table 142. Latin America: Dry Eye Disease Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Dry Eye Disease Sales Forecast by Country (2021-2026) (Kg)
Table 144. Middle East and Africa: Dry Eye Disease Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Dry Eye Disease Players
Table 149. Dry Eye Disease Customers List
Table 150. Dry Eye Disease Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Disease Product Picture
Figure 2. Global Dry Eye Disease Sales Market Share by Type in 2020 & 2026
Figure 3. Artificial Tears Product Picture
Figure 4. Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast) Product Picture
Figure 5. Punctal Plugs Product Picture
Figure 6. Secretagogue Product Picture
Figure 7. Global Dry Eye Disease Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Independent Pharmacies & Drug Stores
Figure 10. Online pharmacies
Figure 11. Dry Eye Disease Report Years Considered
Figure 12. Global Dry Eye Disease Market Size 2015-2026 (US$ Million)
Figure 13. Global Dry Eye Disease Sales 2015-2026 (Kg)
Figure 14. Global Dry Eye Disease Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dry Eye Disease Sales Market Share by Region (2015-2020)
Figure 16. Global Dry Eye Disease Sales Market Share by Region in 2019
Figure 17. Global Dry Eye Disease Revenue Market Share by Region (2015-2020)
Figure 18. Global Dry Eye Disease Revenue Market Share by Region in 2019
Figure 19. Global Dry Eye Disease Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dry Eye Disease Revenue in 2019
Figure 21. Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dry Eye Disease Sales Market Share by Type (2015-2020)
Figure 23. Global Dry Eye Disease Sales Market Share by Type in 2019
Figure 24. Global Dry Eye Disease Revenue Market Share by Type (2015-2020)
Figure 25. Global Dry Eye Disease Revenue Market Share by Type in 2019
Figure 26. Global Dry Eye Disease Market Share by Price Range (2015-2020)
Figure 27. Global Dry Eye Disease Sales Market Share by Application (2015-2020)
Figure 28. Global Dry Eye Disease Sales Market Share by Application in 2019
Figure 29. Global Dry Eye Disease Revenue Market Share by Application (2015-2020)
Figure 30. Global Dry Eye Disease Revenue Market Share by Application in 2019
Figure 31. North America Dry Eye Disease Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Dry Eye Disease Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Dry Eye Disease Sales Market Share by Country in 2019
Figure 34. North America Dry Eye Disease Revenue Market Share by Country in 2019
Figure 35. U.S. Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Dry Eye Disease Market Share by Type in 2019
Figure 40. North America Dry Eye Disease Market Share by Application in 2019
Figure 41. Europe Dry Eye Disease Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Dry Eye Disease Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Dry Eye Disease Sales Market Share by Country in 2019
Figure 44. Europe Dry Eye Disease Revenue Market Share by Country in 2019
Figure 45. Germany Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Dry Eye Disease Market Share by Type in 2019
Figure 56. Europe Dry Eye Disease Market Share by Application in 2019
Figure 57. Asia Pacific Dry Eye Disease Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Dry Eye Disease Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Dry Eye Disease Sales Market Share by Region in 2019
Figure 60. Asia Pacific Dry Eye Disease Revenue Market Share by Region in 2019
Figure 61. China Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Dry Eye Disease Market Share by Type in 2019
Figure 84. Asia Pacific Dry Eye Disease Market Share by Application in 2019
Figure 85. Latin America Dry Eye Disease Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Dry Eye Disease Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dry Eye Disease Sales Market Share by Country in 2019
Figure 88. Latin America Dry Eye Disease Revenue Market Share by Country in 2019
Figure 89. Mexico Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Dry Eye Disease Market Share by Type in 2019
Figure 96. Latin America Dry Eye Disease Market Share by Application in 2019
Figure 97. Middle East and Africa Dry Eye Disease Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Dry Eye Disease Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dry Eye Disease Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dry Eye Disease Revenue Market Share by Country in 2019
Figure 101. Turkey Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dry Eye Disease Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Dry Eye Disease Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Dry Eye Disease Market Share by Type in 2019
Figure 108. Middle East and Africa Dry Eye Disease Market Share by Application in 2019
Figure 109. North America Dry Eye Disease Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 110. North America Dry Eye Disease Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Dry Eye Disease Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 112. Europe Dry Eye Disease Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Dry Eye Disease Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 114. Asia Pacific Dry Eye Disease Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Dry Eye Disease Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 116. Latin America Dry Eye Disease Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Dry Eye Disease Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 118. Middle East and Africa Dry Eye Disease Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…- 炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
- 炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 院内感染症検査の世界市場（～2026年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…